EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection

Hamidreza Karimi-Sari iD, Gregory M Lucas iD, Katie Zook, Brian Weir, Miles Landry, Susan G Sherman, Kathleen R Page iD, Oluwaseun Falade-Nwulia

Viruses · 2024

DOI: 10.3390/v16091416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Hamidreza Karimi-Sari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C, Substance Abuse, Intravenous. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIH HHS, NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus (HCV) infection and hazardous alcohol use are both preventable causes of morbidity and mortality among people who inject drugs (PWID). In the general population, hazardous alcohol is associated with a reduced likelihood of HCV treatment initiation. Less is known about the prevalence and impact of hazardous alcohol use on direct-acting antiviral (DAA) therapy initiation among PWID with active injection drug use.

Methods

PWID were recruited via street outreach in Baltimore, Maryland, between 2018 and 2019 and were enrolled in a study cohort. Participants completed a study survey and underwent HCV testing. Self-reported DAA therapy initiation was evaluated at follow-up visits every six months. Hazardous alcohol use was determined based on an AUDIT-C score of ≥4 for men or ≥3 for women. Data were analyzed using multivariable logistic regression with generalized estimating equations.

Results

Of the 720 PWID recruited, 291 had detectable HCV RNA, and only 134 were aware of their HCV infection. The mean (±standard deviation) age of those that were aware of their infection was 48.7 (±10.3) years, with a slight majority (53.0%) being male and predominantly African American (64.9%). The majority (80/134, 59.7%) met criteria for hazardous alcohol use. Only 16 (11.9%) PWID reported DAA therapy initiation within six months, and 20 (14.9%) reported it within 12 months of follow-up. Hazardous alcohol use (aOR = 1.23, 95% CI = 0.43–3.53) was not associated with DAA treatment initiation.

Conclusions

There was a high prevalence of hazardous alcohol use, low rates of oral DAA therapy initiation, and no association between self-reported hazardous alcohol use and initiation of oral DAA therapy in our sample of PWID that were aware of their chronic HCV infection. Strategies to increase HCV treatment uptake in PWID with active drug use are urgently needed and should integrate alcohol and drug use evaluation and care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis CSubstance Abuse, IntravenousHumansMaleFemaleMiddle AgedAdultHepacivirusAlcohol DrinkingPrevalenceBaltimoreCohort Studies

Stichwörter der Autor:innen

alcohol use disorderantiviral agentshepatitis C virusintravenous drug use

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.

ORCID-Profile: Hamidreza Karimi-Sari, Gregory M Lucas, Kathleen R Page

Förderung

  • NIDA NIH HHS
  • NIH HHS
  • NINR NIH HHS
  • NIAID NIH HHS
  • National Institute on Drug Abuse
  • National Institutes of Health and the Johns Hopkins Center for AIDS Research

Zitieren

APA

Karimi-Sari, H., Lucas, G. M., Zook, K., Weir, B., Landry, M., Sherman, S. G., Page, K. R., & Falade-Nwulia, O. (2024). Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection. Viruses. https://doi.org/10.3390/v16091416

Vancouver

Karimi-Sari H, Lucas GM, Zook K, Weir B, Landry M, Sherman SG, et al. Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection. Viruses. 2024. doi:10.3390/v16091416

BibTeX
@article{KarimiSari2024,
  author = {Karimi-Sari, Hamidreza and Lucas, Gregory M and Zook, Katie and Weir, Brian and Landry, Miles and Sherman, Susan G and Page, Kathleen R and Falade-Nwulia, Oluwaseun},
  title = {Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091416}
}
Kostenlos starten →